These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Surfactant replacement therapy in utero for prevention of hyaline membrane disease in the preterm baboon. Galan HL, Cipriani C, Coalson JJ, Bean JD, Collier G, Kuehl TJ. Am J Obstet Gynecol; 1993 Oct 06; 169(4):817-24. PubMed ID: 8238135 [Abstract] [Full Text] [Related]
7. [Treatment of hyaline membrane disease by administration of exogenous surfactant]. Bonte F, Dehan M, de Fontanges A, Lindenbaum A, Perret L, Puisieux F. Arch Fr Pediatr; 1985 May 06; 42(5):397-402. PubMed ID: 3907577 [No Abstract] [Full Text] [Related]
8. Surfactant 1981. Gupta JM. Med J Aust; 1981 May 30; 1(11):557-8. PubMed ID: 6894778 [No Abstract] [Full Text] [Related]
9. The effects of surfactant on haemodynamics in hyaline membrane disease. Skinner J. Arch Dis Child Fetal Neonatal Ed; 1997 Mar 30; 76(2):F67-9. PubMed ID: 9135282 [No Abstract] [Full Text] [Related]
11. Surfactants in severe hyaline membrane disease. Lancet; 1987 May 02; 1(8540):1040-1. PubMed ID: 2883383 [No Abstract] [Full Text] [Related]
12. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease. Vidyasagar D, Maeta H, Raju TN, John E, Bhat R, Go M, Dahiya U, Roberson Y, Yamin A, Narula A. Pediatrics; 1985 Jun 02; 75(6):1132-42. PubMed ID: 3846883 [Abstract] [Full Text] [Related]
13. [Exogenous surfactants in neonatology]. Zupan V, Meric M, Dehan M. Rev Mal Respir; 1995 Jun 02; 12(6):642-5. PubMed ID: 8677364 [No Abstract] [Full Text] [Related]
14. Pulmonary surfactant replacement in respiratory distress syndrome. Vidyasagar D, Shimada S. Clin Perinatol; 1987 Dec 02; 14(4):991-1015. PubMed ID: 3322633 [Abstract] [Full Text] [Related]
15. Treatment of hyaline membrane disease by human amniotic fluid surfactant. Jin HZ, Chen C, Jin QL, Shao XM. Chin Med J (Engl); 1989 Dec 02; 102(12):944-6. PubMed ID: 2517741 [Abstract] [Full Text] [Related]
16. [Exogenous surfactants. Indications and limits in 1992]. Voyer M, Laudat F, Kochert F, Zeller J. Arch Fr Pediatr; 1992 Apr 02; 49 Suppl 1():237-9. PubMed ID: 1449366 [No Abstract] [Full Text] [Related]
17. [Exogenous surfactants of natural origin. What is new in 1992?]. Walti H, Breart G, Relier JP. Arch Fr Pediatr; 1992 Apr 02; 49 Suppl 1():231-2. PubMed ID: 1449364 [No Abstract] [Full Text] [Related]
18. Ductal shunting and effective systemic blood flow following single dose surfactant treatment in the premature baboon with hyaline membrane disease. Kinsella JP, Gerstmann DR, Gong AK, Taylor AF, deLemos RA. Biol Neonate; 1991 Apr 02; 60(5):283-91. PubMed ID: 1790252 [Abstract] [Full Text] [Related]
19. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study. Victorin LH, Deverajan LV, Curstedt T, Robertson B. Biol Neonate; 1990 Apr 02; 58(3):121-6. PubMed ID: 2279046 [Abstract] [Full Text] [Related]
20. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW. Pediatrics; 1987 Jan 02; 79(1):31-7. PubMed ID: 3540835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]